France’s Innopsys Debuts InnoScan 900 Amidst Flurry of Next-Gen Scanner Launches | GenomeWeb
Innopsys this month will launch a new microarray scanner to meet the needs for higher-resolution imaging of the high-density chips recently released by Agilent Technologies and Roche NimbleGen, according to the Carbonne, France-based firm’s CEO.
 
Stephane Le Brun told BioArray News last week that Innopsys is set to debut the InnoScan 900, a 1-micron resolution system that is the first new system launched by the company since it rolled out the InnoScan 700, a 3-micron resolution system, in 2006.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.